CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Heparin sulfate infusion at 10 units/kg/hour +1 moredrug
Likely dose
Heparin sulfate infusion at 10 units/kg/hourfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00779558
NCT00779558N/ACompleted
CompareCT.gov

Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery

Stanford University·interventional·Posted Oct 24, 2008·Updated Jun 12, 2015

In Brief

A clinical study evaluating Heparin sulfate infusion at 10 units/kg/hour and Placebo infusion for Thrombosis. Completed, enrolled 90 participants across 1 site.

Detailed Summary

Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsThrombosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 24, 2008
Enrollment StartNov 1, 2005
Primary CompletionNov 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 17.7 years ago

Interventions

Heparin sulfate infusion at 10 units/kg/hourdrug

Infusion of heparin to prevent central line thrombosis in infants after cardiac surgery

Placebo infusiondrug

Infusion of normal saline